Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 357 clinical trials
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

Patients with refractory and/or recurrent solid tumor have poor prognosis despite complex multimodel therapy and therefore, novel approaches are urgently needed. This study attempts to treat these diseases using T cells genetically modified with a 4th generation lentiviral chimeric antigen receptor (4SCAR fused with an inducible apoptotic caspase 9 domain) …

kidney function test
metastasis
neutrophil count
monoclonal antibodies
platelet count
  • 0 views
  • 19 Feb, 2024
  • 3 locations
Evaluation of a Virtual Reality Tool for Identifying the Cognitive Functions of the Right Hemisphere in Patients With Glioma -TANGO

Evaluate the diagnostic performance of a virtual reality application to detect the presence of cognitive impairment of the non-dominant hemisphere in patients with glioma

cognitive impairment
  • 0 views
  • 19 Feb, 2024
  • 1 location
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

This trial studies whether a customized video intervention can help to reduce anxiety in brain cancer patients undergoing radiation treatment and their caregivers. A customized neuro-imaging referenced symptom video that describes symptoms and side effects specific to the patients' tumor may result in an early and sustained reduction in anxiety …

anxiety
brain tumor
cancer
MRI
psychiatric symptoms
  • 0 views
  • 19 Feb, 2024
  • 1 location
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Objective To learn the highest dose of selinexor that people with brain cancer can tolerate when given with temozolomide and radiation therapy. Eligibility People ages 18 and older with brain cancer that has not been treated with chemotherapy or radiation Design Participants will be screened under another protocol.

external beam radiotherapy
absolute neutrophil count
cancer
platelet count
therapeutic agents
  • 0 views
  • 19 Feb, 2024
  • 1 location
Restrictive Use of Dexamethasone in Glioblastoma

The administration of steroids, most commonly dexamethasone (DEX), has established as standard of care during treatment of glioblastoma (GBM) and is widely used during the entire course of the disease including pre- and postoperative management, chemo- and radiotherapy. The primary purpose is to reduce tumor-associated vasogenic edema and to prevent …

immunosuppression
glioblastoma multiforme
dexamethasone
neurologic symptoms
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cerebral Morbidity After Radiation Therapy for Brain Tumors

All types of brain tumours apart from glioblastoma will be included.

meningioma
medulloblastoma
sarcoma
anaplastic astrocytoma
pituitary
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Hyperlactatemia During and After Tumorcraniotomy

This study aims to investigate the association between hyperlactatemia and neurological disability, length-of-stay and mortality in patients who undergo tumorcraniotomy. The risk factors that induce lactat accumulation will also be explored.

hyperlactatemia
craniotomy
  • 0 views
  • 19 Feb, 2024
  • 1 location